These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7756795)

  • 1. Levels of SP-A-anti-SP-A immune complexes in neonatal respiratory distress syndrome correlate with subsequent development of bronchopulmonary dysplasia.
    Strayer DS; Merritt TA; Hallman M
    Acta Paediatr; 1995 Feb; 84(2):128-31. PubMed ID: 7756795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant replacement: immunological considerations.
    Strayer DS; Merritt TA; Hallman M
    Eur Respir J Suppl; 1989 Mar; 3():91s-96s. PubMed ID: 2742687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
    Chida S; Phelps DS; Soll RF; Taeusch HW
    Pediatrics; 1991 Jul; 88(1):84-9. PubMed ID: 2057277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary surfactant protein A in sera for assessing neonatal lung maturation.
    Kaneko K; Shimizu H; Arakawa H; Ogawa Y
    Early Hum Dev; 2001 Apr; 62(1):11-21. PubMed ID: 11245991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
    Hallman M; Merritt TA; Akino T; Bry K
    Am Rev Respir Dis; 1991 Dec; 144(6):1376-84. PubMed ID: 1741552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome.
    Strayer DS; Merritt TA; Lwebuga-Mukasa J; Hallman M
    Am J Pathol; 1986 Feb; 122(2):353-62. PubMed ID: 3511728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants.
    Weber B; Borkhardt A; Stoll-Becker S; Reiss I; Gortner L
    Turk J Pediatr; 2000; 42(3):181-5. PubMed ID: 11105614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of respiratory distress syndrome by the level of pulmonary surfactant protein A in cord blood sera.
    Cho K; Matsuda T; Okajima S; Matsumoto Y; Sagawa T; Fujimoto S; Kobayashi K
    Biol Neonate; 2000 Feb; 77(2):83-7. PubMed ID: 10657683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
    Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
    Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between reduced expression of surfactant protein B and neonatal respiratory distress syndrome in twenty Han ethnic group neonates in China].
    Yin XJ; Luo FP; Li AH; An YL; Feng ZC
    Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):9-12. PubMed ID: 18353230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
    Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in-house ELISA method for measuring surfactant protein A.
    Cheong KB; Cheong SK; Boo NY; Jemilah M; Ton SH
    Malays J Pathol; 1995 Dec; 17(2):91-6. PubMed ID: 8935133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.